3pbl
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Structure of the human dopamine D3 receptor in complex with eticlopride== | ==Structure of the human dopamine D3 receptor in complex with eticlopride== | ||
<StructureSection load='3pbl' size='340' side='right' caption='[[3pbl]], [[Resolution|resolution]] 2.89Å' scene=''> | <StructureSection load='3pbl' size='340' side='right' caption='[[3pbl]], [[Resolution|resolution]] 2.89Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3pbl]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3pbl]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3PBL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3PBL FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ETQ:3-CHLORO-5-ETHYL-N-{[(2S)-1-ETHYLPYRROLIDIN-2-YL]METHYL}-6-HYDROXY-2-METHOXYBENZAMIDE'>ETQ</scene>, <scene name='pdbligand=MAL:MALTOSE'>MAL</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ETQ:3-CHLORO-5-ETHYL-N-{[(2S)-1-ETHYLPYRROLIDIN-2-YL]METHYL}-6-HYDROXY-2-METHOXYBENZAMIDE'>ETQ</scene>, <scene name='pdbligand=MAL:MALTOSE'>MAL</scene></td></tr> | ||
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">DRD3, E ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id= | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">DRD3, E ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3pbl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3pbl OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3pbl RCSB], [http://www.ebi.ac.uk/pdbsum/3pbl PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3pbl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3pbl OCA], [http://pdbe.org/3pbl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3pbl RCSB], [http://www.ebi.ac.uk/pdbsum/3pbl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3pbl ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 20: | Line 21: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 3pbl" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
+ | *[[Dopamine Receptors|Dopamine Receptors]] | ||
*[[Dopamine receptor|Dopamine receptor]] | *[[Dopamine receptor|Dopamine receptor]] | ||
*[[Lysozyme 3D structures|Lysozyme 3D structures]] | *[[Lysozyme 3D structures|Lysozyme 3D structures]] | ||
Line 28: | Line 31: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Human]] |
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
[[Category: ATCG3D, Accelerated Technologies Center for Gene to 3D Structure]] | [[Category: ATCG3D, Accelerated Technologies Center for Gene to 3D Structure]] |
Revision as of 19:34, 5 August 2016
Structure of the human dopamine D3 receptor in complex with eticlopride
|
Categories: Human | Lysozyme | ATCG3D, Accelerated Technologies Center for Gene to 3D Structure | Cherezov, V | Chien, E Y.T | GPCR, GPCR Network | Han, G W | Katritch, V | Liu, W | Stevens, R C | Zhao, Q | Accelerated technologies center for gene to 3d structure | Atcg3d | Chimera | Dopamine | Eticlopride | G protein-coupled receptor | Gpcr | Gpcr network | Hydrolase | Hydrolase-hydrolase inhibitor complex | Membrane protein | Neurotransmitter | PSI, Protein structure initiative | Psi-biology | Signal transduction | Structural genomic | T4l fusion | Transmembrane